Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-21-000519
Filing Date
2021-01-26
Accepted
2021-01-26 11:04:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 NANOVIRICIDES, INC. p21-0201sc13ga.htm SC 13G/A 71553
  Complete submission text file 0000902664-21-000519.txt   72997
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Subject) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-90672 | Film No.: 21552251
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

EIN.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A